BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8487246)

  • 1. Relationship between cardiovascular haemodynamics and goals of antihypertensive therapy.
    Lund-Johansen P
    J Hum Hypertens; 1993 Feb; 7 Suppl 1():S21-8. PubMed ID: 8487246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of vasodilating beta-blockers on cardiac function and vascular resistance in essential hypertension.
    Lund-Johansen P
    Clin Nephrol; 1992; 38 Suppl 1():S78-86. PubMed ID: 1363538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodynamic profiles of antihypertensive agents.
    Lund-Johansen P
    Blood Press Suppl; 1992; 1():16-22; discussion 23. PubMed ID: 1343266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Essential hypertension: hemodynamic and therapeutic changes over 20 years.
    Lund-Johansen P
    J Cardiovasc Pharmacol; 1991; 18 Suppl 4():S1-7. PubMed ID: 1721971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. alpha-Methyldopa and beta-blockers in hypertension--a comparison of their haemodynamic effects.
    Lund-Johansen P
    Clin Exp Pharmacol Physiol Suppl; 1978; 4():23-34. PubMed ID: 28190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of antihypertensive therapy on the hemodynamics of hypertension: clinical implications.
    Lund-Johansen P
    Clin Ther; 1986; 8(4):382-97. PubMed ID: 3524841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antihypertensive therapy and cardiovascular reactivity during isometric stress.
    Garavaglia GE; Messerli FH; Schmieder RE; Nunez BD
    J Hum Hypertens; 1988 Dec; 2(4):247-51. PubMed ID: 3236326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the hemodynamic effects of five calcium channel blockers at rest and during exercise in essential hypertension.
    Omvik P; Lund-Johansen P
    Ann Clin Res; 1988; 20 Suppl 48():23-30. PubMed ID: 3250315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacology of combined alpha-beta-blockade. II. Haemodynamic effects of labetalol.
    Lund-Johansen P
    Drugs; 1984; 28 Suppl 2():35-50. PubMed ID: 6151890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal haemodynamics in hypertension: effects of antihypertensive drugs.
    Dupont AG
    J Hum Hypertens; 1993 Feb; 7 Suppl 1():S42-5. PubMed ID: 8487249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic, pulmonary and coronary haemodynamic actions of the novel dopamine receptor agonist in awake pigs at rest and during treadmill exercise Z1046.
    Duncker DJ; Haitsma DB; van der Geest IE; Stubenitsky R; van Meegen JR; Man in't Veld AJ; Verdouw PD
    Br J Pharmacol; 1997 Mar; 120(6):1101-13. PubMed ID: 9134223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discordant effects of beta-blockade on central aortic systolic and brachial systolic blood pressure: considerations beyond the cuff.
    Epstein BJ; Anderson S
    Pharmacotherapy; 2007 Sep; 27(9):1322-33. PubMed ID: 17723086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacotherapy of different forms of hypertension in childhood].
    Seyberth HW
    Padiatr Padol; 1987; 22(4):365-78. PubMed ID: 3325889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The metabolic syndrome in hypertension: European society of hypertension position statement.
    Redon J; Cifkova R; Laurent S; Nilsson P; Narkiewicz K; Erdine S; Mancia G;
    J Hypertens; 2008 Oct; 26(10):1891-900. PubMed ID: 18806611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Retrospective studies and prospects of therapy for hypertension].
    Maisch B; Brilla C; Kruse T; Noll B; Bethge C
    Herz; 1995 Dec; 20(6):370-89. PubMed ID: 8582697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effective antihypertensive therapy: blood pressure control with moxonidine.
    Prichard BN; Graham BR
    J Cardiovasc Pharmacol; 1996; 27 Suppl 3():S38-48. PubMed ID: 8872298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypertension in elderly--an overview.
    Bhattacharyya A; Das P
    J Indian Med Assoc; 1999 Mar; 97(3):96-101. PubMed ID: 10652909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacology and clinical use of moxonidine, a new centrally acting sympatholytic antihypertensive agent.
    Prichard BN; Owens CW; Graham BR
    J Hum Hypertens; 1997 Aug; 11 Suppl 1():S29-45. PubMed ID: 9321737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term hemodynamic effects of antihypertensive treatment.
    Lund-Johansen P; Omvik P; Nordrehaug JE
    Clin Investig; 1992; 70 Suppl 1():S58-64. PubMed ID: 1350486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemodynamic effects of antihypertensive drugs.
    Itskovitz HD
    Am Fam Physician; 1983 Jun; 27(6):137-42. PubMed ID: 6134461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.